JONAH A SCHEY
Allopathic & Osteopathic Physicians|Pediatrics BOSTON, MA NPI 1609215904
Browse related groups: Allopathic & Osteopathic Physicians|Pediatrics MA PFIZER INC. All categories
General Payments — all program years on this page
$330.73
- Category: General Payments
- Program years: PY2020–2024
- Record count: 17
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $175.35 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $175.35 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $52.05 | 2 |
| Mirum Pharmaceuticals, Inc. | $41.98 | 2 |
| Seqirus USA Inc | $33.63 | 2 |
| Acerta Pharma LLC | $17.06 | 1 |
| GlaxoSmithKline, LLC. | $15.82 | 1 |
| Cranial Technologies, Inc | $14.81 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1082229930 | Cranial Technologies, Inc | $14.81 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104258329 | AstraZeneca Pharmaceuticals LP | $17.06 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115977227 | GlaxoSmithKline, LLC. | $15.82 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1123323033 | Mirum Pharmaceuticals, Inc. | $17.69 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1123323035 | Mirum Pharmaceuticals, Inc. | $24.29 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1125635601 | Seqirus USA Inc | $17.40 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1125635651 | Seqirus USA Inc | $16.23 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131388261 | PFIZER INC. | $23.46 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131431936 | PFIZER INC. | $28.59 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.